Innospec Set to Join the S&P SmallCap 600

Aug 20, 2015, 18:38 ET from S&P Dow Jones Indices

NEW YORK, Aug. 20, 2015 /PRNewswire/ -- Innospec Inc. (NASD:IOSP) will replace Bio-Reference Laboratories Inc. (NASD:BRLI) in the S&P SmallCap 600 after the close of trading on Friday, August 21. OPKO Health Inc. (NYSE: OPK) is acquiring Bio-Reference Laboratories in a deal that closed today.

Innospec develops, manufactures, blends, markets, and supplies fuel additives, oilfield chemicals, and other specialty chemicals. Headquartered in Englewood, CO, the company will be added to the S&P SmallCap 600 GICS (Global Industry Classification Standard) Specialty Chemicals Sub-Industry index.

Following is a summary of the change:

S&P SMALLCAP 600 INDEX – August 21, 2015







Specialty Chemicals


Bio-Reference Laboratories

Health Care

Health Care Services

Additions to and deletions from S&P  Dow Jones Indices do not in any way reflect an opinion on the investment merits of the companies involved.

About S&P Dow Jones Indices

S&P Dow Jones Indices LLC, a part of McGraw Hill Financial, is the world's largest, global resource for index-based concepts, data and research. Home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®, S&P Dow Jones Indices LLC has over 115 years of experience constructing innovative and transparent solutions that fulfill the needs of investors. More assets are invested in products based upon our indices than any other provider in the world. With over 1,000,000 indices covering a wide range of asset classes across the globe, S&P Dow Jones Indices LLC defines the way investors measure and trade the markets. To learn more about our company, please visit  

S&P® is a registered trademark of Standard & Poor's Financial Services LLC ("S&P"), a part of McGraw Hill Financial. Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC ("Dow Jones").  These trademarks have been licensed to S&P Dow Jones Indices LLC. It is not possible to invest directly in an index. S&P Dow Jones Indices LLC, Dow Jones, S&P and their respective affiliates (collectively "S&P Dow Jones Indices") do not sponsor, endorse, sell, or promote any investment fund or other investment vehicle that is offered by third parties and that seeks to provide an investment return based on the performance of any index. This document does not constitute an offer of services in jurisdictions where S&P Dow Jones Indices does not have the necessary licenses. S&P Dow Jones Indices receives compensation in connection with licensing its indices to third parties.

For more information:

David Blitzer  Managing Director and Chairman of the Index Committee  S&P Dow Jones Indices  (+1) 212 438 3907 

David R. Guarino  Communications  S&P Dow Jones Indices  (+1) 212 438 1471



SOURCE S&P Dow Jones Indices